1. Targeted therapies for solid tumors: is the dream becoming a reality?

   • Martine J. Piccart-Gebhart
   • Ahmad Awada

   Editorial 19 May 2006 Pages: 113 - 113

2. Phase II combination of gefitinib and docetaxel for advanced or metastatic non-small cell lung cancer: clinical results and biological monitoring

   • M. Gatineau
   • E. Dansin
   • O. Rixe

   Original Research 27 June 2006 Pages: 114 - 122

   

3. Combination of epidermal growth factor receptor inhibitors and antiangiogenic drugs: a model for treatment

   • Erika Martinelli
   • Teresa Troiani
   • Fortunato Ciardiello

   Review 19 May 2006 Pages: 123 - 129

4. Reovirus and other oncolytic viruses for the targeted treatment of cancer

   • L. Vidal
   • T. A. Yap
   • J. S. de Bono

   Review 29 June 2006 Pages: 130 - 150

   

5. Clinical phosphoproteomic profiling for personalized targeted medicine using reverse phase protein microarray

   • Gerhard S. Mundinger
   • Virginia Espina
   • Katherine R. Calvo

   Perspectives 17 June 2006 Pages: 151 - 167

   

6. Simultaneously occurring chronic myelogenous leukemia and gastrointestinal stromal tumors treated with imatinib

   • Y. Mishima
   • Y. Terui
   • K. Hatake

   Day-to-day Practice 17 June 2006 Pages: 168 - 171

   

7. Hypertension and targeted therapy

   • Simon Chowdhury
   • James F. Spicer
   • Peter G. Harper

   Day-to-day Practice 15 June 2006 Pages: 172 - 178